New York Overdose Deaths Continue Falling, but Annual Decline Slows to About 8%

New York recorded fewer drug overdose deaths in the latest 12-month period, although the pace of improvement has slowed significantly. The Centers for Disease Control and Prevention’s provisional predictions list approximately 3,650 overdose deaths statewide in the 12 months ending May 2026, about 8% fewer than the 3,985 estimated for the same period a year earlier.

The slowdown follows several years of unusually steep reductions. New York’s Office of Addiction Services and Supports reports that the state recorded 1,800 fewer overdose deaths in 2024 than in 2023, a 30% decrease. The decline continued in 2025, producing a two-year reduction of more than 40%. In an August 31 statement, Gov. Kathy Hochul’s office said predicted deaths fell from more than 6,630 in 2022 to 3,775 in 2025, a decrease the office described as about 45%.

Although the trend remains encouraging, the toll is still substantial. Thousands of New York households lose a relative to overdose each year, and fentanyl and other synthetic opioids were involved in about 60% of the state’s overdose deaths during the latest 12-month period.

Some recent reports have overstated the scale of the latest annual decline. A Spectrum News report on Rochester recovery groups cited CDC data showing an overall decrease of 41% for the 12 months ending May 2026. The CDC’s current figures do not support that figure: New York’s decline was about 8%, compared with approximately 11.5% nationally. The statewide reduction of more than 40% covers two years, not one.

New York’s Overdose Numbers by Region

The CDC reports New York City separately from the rest of the state. Outside the five boroughs, predicted overdose deaths fell from 1,941 to 1,783, a decrease of about 8%. In New York City, deaths declined from 2,044 to 1,869, or roughly 9%.

Nationally, the CDC estimates 66,478 overdose deaths in the 12 months ending May 2026, down approximately 11.5% from 75,094 a year earlier.

These estimates remain provisional. The CDC classifies its most recent counts, including New York’s, as underreported because some data have not yet been submitted. Although the predictions account for typical reporting delays, the agency says final figures are needed to confirm the extent of the decline.

Fentanyl Deaths Decline as Cocaine Deaths Remain Flat in New York City

Statewide, deaths involving synthetic opioids fell from approximately 2,537 to 2,194, a reduction of about 13.5%. Outside New York City, synthetic-opioid deaths declined by roughly 16%, while the decrease in the five boroughs was about 11%.

Cocaine-involved deaths in New York City showed little change. Predicted deaths stood at 1,113, compared with 1,110 a year earlier. By contrast, heroin-involved deaths in the city fell from 360 to 275.

Because a single death can involve more than one drug, it may be included in both the cocaine and synthetic-opioid categories, according to the CDC’s technical notes. This overlap is an important public-health concern because people who use only stimulants may still encounter fentanyl in the illicit drug supply.

New York City’s own data illustrate the continuing toll. The Health Department confirmed 456 overdose deaths in the third quarter of 2025, with opioids involved in approximately 78% of them. According to the department’s latest quarterly report, someone dies of an overdose in New York City every five hours.

State officials acknowledge that progress has not eliminated the loss of life. “While we have made significant progress in reducing deaths, we continue to lose too many New Yorkers,” OASAS Commissioner Dr. Chinazo Cunningham said in the governor’s August statement.

Naloxone Access and Resources for New York Households

The risk of overdose death varies significantly across the state. OASAS data show the highest death rates among men ages 35 to 64. Black New Yorkers have the highest rates, followed by American Indian or Alaska Native and Hispanic or Latino residents. Bronx County has the highest county-level rate in the state.

Public health officials emphasize that households should keep naloxone readily available and know how to administer it. Registered opioid overdose prevention programs provide free naloxone and training throughout New York. Naloxone nasal spray is also available over the counter, and the state covers pharmacy copayments of up to $40, according to the city Health Department. Residents can also order free naloxone and drug test strips online through OASAS.

Signs of an opioid overdose include unresponsiveness, slow or stopped breathing, and blue or gray lips. Anyone who observes these symptoms should call 911 and administer naloxone immediately. People seeking assistance for themselves or a loved one can call the state’s 24/7 HOPEline at 1-877-8-HOPENY (1-877-846-7369) or text HOPENY to 467369.

Local recovery groups say flexible harm-reduction strategies are essential to preventing avoidable deaths. “There are multiple pathways to recovery, and focusing on just a few causes harm,” said Stephanie Forrester, a founder of the Rochester nonprofit Recovery All Ways, in an interview with Spectrum News. Spectrum News also reported that the Substance Abuse and Mental Health Services Administration said earlier in the year that its funding could no longer be used to purchase drug test strips, a change that has concerned many local organizations.

What the Next CDC Update May Show

The CDC updates its provisional overdose dashboard monthly. Its next release is expected to include data through June 2026. Subsequent updates will help determine whether New York’s slower decline is a lasting trend or partly reflects reporting delays.

Several questions remain unanswered. In a study published June 2 in the journal Addiction, researchers at UC San Diego said the national decline is likely driven by a combination of factors. These include fewer people at high risk, greater awareness of fentanyl, broader naloxone access, changes in drug use and possible disruptions to the fentanyl supply. No single cause has been confirmed, and officials have not explained why cocaine-involved deaths in New York City have stopped declining.

New York has reduced overdose deaths sharply since 2022, but its latest annual decline is about 8%. Carrying naloxone, learning how to recognize an overdose and using available state resources can reduce risk while public health officials work to determine why progress has slowed.

Key Questions Answered

How much did New York overdose deaths fall in the latest year? The CDC’s predicted provisional counts show about 3,650 overdose deaths statewide in the 12 months ending May 2026, down approximately 8% from about 3,985 a year earlier.

Did New York overdose deaths fall by 41% in a single year? No. The CDC’s current data show a one-year decline of about 8% in New York and approximately 11.5% nationwide. The statewide reduction of more than 40% covers two years.

Is fentanyl still the leading cause of overdose deaths in New York? Yes. Synthetic opioids, primarily fentanyl, were involved in about 60% of the state’s overdose deaths during the latest period, even as synthetic-opioid deaths declined by approximately 13.5%.

Which populations face the greatest overdose risk in New York? State data show the highest death rates among men ages 35 to 64, Black New Yorkers and residents of Bronx County.

Where can New Yorkers obtain naloxone? Registered opioid overdose prevention programs offer free naloxone and training. Pharmacies sell naloxone over the counter, the state covers copayments of up to $40, and OASAS provides free naloxone through an online order form.

When will the next overdose data be released? The CDC updates its provisional overdose dashboard monthly. The next update is expected to include deaths through June 2026.

Source link